A5103164926- Inflammatory Bowel Disease
- COVID-19 and healthcare impacts
- Colorectal Cancer Screening and Detection
- Genetic factors in colorectal cancer
- Healthcare cost, quality, practices
- Radiomics and Machine Learning in Medical Imaging
- Gastric Cancer Management and Outcomes
- Infection Control and Ventilation
- COVID-19 Clinical Research Studies
- Diagnosis and treatment of tuberculosis
- Tuberculosis Research and Epidemiology
- Diverticular Disease and Complications
- bioluminescence and chemiluminescence research
- Healthcare Systems and Challenges
- Liver Diseases and Immunity
- Microscopic Colitis
- Gastrointestinal Bleeding Diagnosis and Treatment
- Autoimmune and Inflammatory Disorders
University College Cork
2024-2025
APC Microbiome Institute
2024
University Hospitals Birmingham NHS Foundation Trust
2019-2022
Queen Elizabeth Hospital
2021
University of Birmingham
2019-2020
NIHR Birmingham Biomedical Research Centre
2019-2020
Bipar
2020
University of Calgary
2019
Queen Elizabeth Hospital Birmingham
2019
National Institute for Health Research
2019
Abstract Background Achieving histological remission is a desirable treatment target in inflammatory bowel disease (IBD)1, yet its assessment challenged by high inter- and intra-observer variability, reliance on experts, lack of standardisation2. Artificial intelligence (AI) holds promise addressing these issues3. This systematic review, meta-analysis, meta-regression evaluated the AI’s performance assessing compared it with that pathologists. Methods We searched Medline/PubMed Scopus...
Background and Aim The aim of this randomized trial was to evaluate the performance self‐training versus didactic training in order increase diagnostic accuracy diminutive/small colonic polyp histological prediction by trainees. Methods Sixteen trainees reviewed 78 videos (48 iSCAN ‐ OE 30 NBI ) polyps a pretraining assessment. Trainees were receive computer‐based self‐learning ( n = 8) or using identical teaching materials videos. same videos, different order, assessed. NICE International...
Performance of diagnostic or therapeutic endoscopic procedures in inflammatory bowel disease (IBD) patients can be challenging during a viral pandemic; the main concerns being safety and protection health care providers (HCP). The aim this study is to identify practice patterns outcomes IBD coronavirus 19 (COVID-19) with worldwide survey HCP.
Background: Patients with inflammatory bowel disease (IBD) are susceptible to viral infection, which may include SARS-CoV-2. The management of IBD and COVID-19 can be challenging, as the majority patients on some immunosuppressive medications. aim this study is identify practice patterns, strategy, outcomes a world-wide survey health care providers. Methods: 22-item questionnaires were sent community worldwide, including providers from epicenter countries at different time points, such...
Abstract Background Chronic ulcerative colitis is an inflammatory condition associated with a pro-neoplastic drive, predisposing to colorectal cancer. Repeated colonoscopy undertaken detect preneoplastic change, but cancer diagnosis still frequently missed. Aims To determine if predetermined panel of methylation markers could better risk stratify patients, aiding earlier detection neoplasia. Methods ENDCaP-C ( https://doi.org/10.1186/ISRCTN81826545 ) was prospective multicentre test accuracy...
Background Chronic ulcerative colitis is a large bowel inflammatory condition associated with increased colorectal cancer risk over time, resulting in 1000 colectomies per year the UK. Despite intensive colonoscopic surveillance, 50% of cases progress to invasive before detection. Detecting early (precancer) molecular changes by analysing biopsies from routine colonoscopy should increase neoplasia Objectives To establish deoxyribonucleic acid (DNA) marker panel neoplastic patients. develop...